PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 93 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $2,000 | 0.0% | 392 | 0.0% | 0.00% | – |
Q4 2021 | $2,000 | 0.0% | 392 | 0.0% | 0.00% | – |
Q3 2021 | $2,000 | 0.0% | 392 | 0.0% | 0.00% | – |
Q2 2021 | $2,000 | 0.0% | 392 | +79.8% | 0.00% | – |
Q1 2021 | $2,000 | 0.0% | 218 | 0.0% | 0.00% | – |
Q4 2020 | $2,000 | – | 218 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 218 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 218 | -4.0% | 0.00% | – |
Q1 2020 | $0 | – | 227 | -23.8% | 0.00% | – |
Q4 2019 | $0 | -100.0% | 298 | +30.7% | 0.00% | – |
Q3 2019 | $1,000 | – | 228 | +103.6% | 0.00% | – |
Q2 2019 | $0 | – | 112 | -19.4% | 0.00% | – |
Q1 2019 | $0 | – | 139 | +6.9% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 130 | +16.1% | 0.00% | – |
Q3 2018 | $2,000 | 0.0% | 112 | 0.0% | 0.00% | – |
Q2 2018 | $2,000 | -83.3% | 112 | -88.7% | 0.00% | – |
Q1 2018 | $12,000 | -25.0% | 992 | +6.4% | 0.00% | – |
Q4 2017 | $16,000 | -27.3% | 932 | +5.9% | 0.00% | – |
Q3 2017 | $22,000 | 0.0% | 880 | 0.0% | 0.00% | – |
Q2 2017 | $22,000 | – | 880 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 2,339,107 | $10,502,000 | 3.20% |
Telemetry Investments, L.L.C. | 262,279 | $1,178,000 | 1.52% |
Bruce & Co., Inc. | 1,443,312 | $6,480,000 | 1.30% |
Omega Fund Management, LLC | 1,971,241 | $8,851,000 | 1.25% |
Worth Venture Partners, LLC | 556,832 | $2,500,000 | 1.24% |
Abingworth LLP | 1,041,131 | $4,654,000 | 1.13% |
1492 Capital Management LLC | 491,033 | $2,205,000 | 1.09% |
CM Management, LLC | 300,000 | $1,347,000 | 1.02% |
Trellus Management Company, LLC | 295,000 | $1,325,000 | 0.88% |
GENERAL AMERICAN INVESTORS CO INC | 1,306,919 | $5,868,000 | 0.46% |